Martin W. Hetzer
Member of the NOMIS Foundation board of directors
Organization
Institute of Science and Technology Austria (ISTA)
NOMIS Foundation
About Martin W. Hetzer
Martin W. Hetzer is a NOMIS board member and the president and CEO of the Institute of Science and Technology Austria (ISTA). He led the Determining Biological Age in Humans project.
Hetzer received his PhD in biochemistry and genetics from the University of Vienna (Austria), and completed postdoctoral work at the European Molecular Biology Laboratory (EMBL; Heidelberg, Germany). He joined the faculty at the Salk Institute for Biological Studies (La Jolla, US) in 2004 and became a full professor in 2011. He has received numerous awards, including a Pew Scholar Award, an Early Life Scientist Award from the American Society of Cell Biology, a Senior Scholar Award for Aging from the Ellison Medical Foundation, a Senior Scholar Award from the American Cancer Society, a Royal Society Research Merit Award and the Glenn Award for Research in Biological Mechanisms of Aging. Hetzer was the Jesse and Caryl Philips Professor of Molecular and Cell Biology and the director of the Waitt Advanced Biophotonics Center at the Salk Institute until 2023, when he was appointed president and CEO of ISTA.
His research focuses on fundamental aspects of organismal aging with special emphasis on the heart and central nervous system. His laboratory has also made important contributions to the field of cancer research and cell differentiation.
‘s projects
Determining Biological Age in Humans
Researchers at the Salk Institute have taken on the challenge of developing a scientific method that shows to what extent molecular events determine the rate of aging in humans, which differs significantly from individual to individual. This explains why a person’s chronological age is not the most useful predictor of health. Recent analyses based on […]
NOMIS researcher
Project period
2016 – 2023
‘s publications
Lifelong persistence of nuclear RNAs in the mouse brain
Genomic DNA that resides in the nuclei of mammalian neurons can be as old as the organism itself. The life span of nuclear RNAs, which are critical for proper chromatin architecture and transcription regulation, has not been determined in adult tissues. In this work, we identified and characterized nuclear RNAs that do not turn over for at least 2 years in a subset of postnatally born cells in the mouse brain. These long-lived RNAs were stably retained in nuclei in a neural cell type–specific manner and were required for the maintenance of heterochromatin. Thus, the life span of neural cells may depend on both the molecular longevity of DNA for the storage of genetic information and also the extreme stability of RNA for the functional organization of chromatin.
Research Fields
Biology, Genetics & Heredity
Caspase-mediated nuclear pore complex trimming in cell differentiation and endoplasmic reticulum stress
During apoptosis, caspases degrade 8 out of ~30 nucleoporins to irreversibly demolish the nuclear pore complex. However, for poorly understood reasons, caspases are also activated during cell differentiation. Here, we show that sublethal activation of caspases during myogenesis results in the transient proteolysis of four peripheral Nups and one transmembrane Nup. ‘Trimmed’ NPCs become nuclear export-defective, and we identified in an unbiased manner several classes of cytoplasmic, plasma membrane, and mitochondrial proteins that rapidly accumulate in the nucleus. NPC trimming by non-apoptotic caspases was also observed in neurogenesis and endoplasmic reticulum stress. Our results suggest that caspases can reversibly modulate nuclear transport activity, which allows them to function as agents of cell differentiation and adaptation at sublethal levels. © 2023, eLife Sciences Publications Ltd. All rights reserved.
Research Fields
Health Sciences
Disulfide bond in SUN2 regulates dynamic remodeling of LINC complexes at the nuclear envelope
The LINC complex tethers the cell nucleus to the cytoskeleton to regulate mechanical forces during cell migration, differentiation, and various diseases. The function of LINC complexes relies on the interaction between highly conserved SUN and KASH proteins that form higher-order assemblies capable of load bearing. These structural details have emerged from in vitro assembled LINC complexes; however, the principles of in vivo assembly remain obscure. Here, we report a conformation-specific SUN2 antibody as a tool to visualize LINC complex dynamics in situ. Using imaging, biochemical, and cellular methods, we find that conserved cysteines in SUN2 undergo KASH-dependent inter- and intramolecular disulfide bond rearrangements. Disruption of the SUN2 terminal disulfide bond compromises SUN2 localization, turnover, LINC complex assembly in addition to cytoskeletal organization and cell migration. Moreover, using pharmacological and genetic perturbations, we identify components of the ER lumen as SUN2 cysteines redox state regulators. Overall, we provide evidence for SUN2 disulfide bond rearrangement as a physiologically relevant structural modification that regulates LINC complex functions. © 2023 Sharma and Hetzer.
Research Fields
Biomedical Research, Developmental Biology, Health Sciences
‘s news
January 9, 2023
Martin Hetzer becomes second president of the Institute of Science and Technology Austria
NOMIS Board Member Martin Hetzer has become the Institute of Science and Technology Austria’s second president. The new role for Hetzer was announced last year. After 19 years at the prominent Salk Institute in California, the award-winning molecular biologist returns to Austria to lead the internationally renowned research institute ISTA as President and CEO. The […]
February 22, 2022
Martin Hetzer appointed president of ISTA
NOMIS board member Martin Hetzer has been appointed president of the Institute of Science and Technology Austria, a NOMIS partner institution, effective January 2023. Hetzer is currently a senior vice president and chief science officer at the Salk Institute, also a NOMIS partner. Molecular biologist Martin Hetzer, who has spent close to 20 years conducting […]
September 20, 2020
Martin Hetzer: Method to derive blood vessel cells from skin cells suggests ways to slow aging
NOMIS scientist and board member Martin Hetzer and his colleagues at the Salk Institute for Biological Studies have discovered the ways cells from the human circulatory system change with age and age-related diseases. LA JOLLA—Salk scientists have used skin cells called fibroblasts from young and old patients to successfully create blood vessels cells that retain […]
